Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC2631
Salmonella is the type of bacteria that’s the most frequently reported cause of food-related illness causing an upset stomach, diarrhea, fever, and pain and cramping in patients belly.
Market Dynamics
Gradual increase in number of patients suffering from food infection and increasing awareness among consumers related to salmonella infection are major factors expected to drive the growth of global salmonella treatment market. According to U.S. Department of Health & Human Services, as of December 2020, a total of 1,722 people infected with one of the outbreak strains of Salmonella were reported from all 50 states in the US. Total 333 people (33% of those with information available) were hospitalized. Consumption of unhealthy food or drinking contaminated water is resulting in consumers affecting by bacterial disease. Food illness is impacting consumers and the government to a higher extent. Rise in mortality due to food problem is increasing the concern among the regulatory bodies. The Centers for Disease Control and Prevention (CDC) estimates that each year, 16% of US residents get sick from contaminated foods or beverages. Moreover, it records around 3,000 annual deaths from this occurrence. The US Department of Agriculture estimates an annual loss of more than US$15.6 billion due to foodborne illnesses. In 2020, European Innovation Council awarded US$ 3.0 Mn to SwissDeCode for the development of rapid on-site food testing and certification platform. The company is focused to launch a fully automated system that will perform the same test as laboratories, including certification, in a fraction of the time and directly at the point of need.
Increasing government spending on development R&D facilities is resulting in players focus on the development of new testing and treatment methods. In 2021, Thermo Fisher Scientific, a global healthcare product & service provider launched RapidFinder Salmonella Multiplex Kit with the focus to detect Salmonella species, such as Typhimurium and Enteritidis in under 16 hours. This is expected to augment the growth of target market. Factors such as lack of developed food control resources and infrastructure in developing countries is expected to hamper the growth of global salmonella treatment market. However, increasing investment by major players for development of advanced testing methods, developing food regulations and rise in awareness among consumers related to treatment are factors expected to create new opportunities for players operating in the target market over the forecast period. In addition, major players approach towards enhancing the business through strategic merger is expected to support the revenue transaction of the salmonella treatment market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global salmonella treatment market due to high patient pool suffering from food illness. According to CDC total, 1,642 people were confirmed infected, with 1,012 in the United States and the rest in Canada. Availability of advanced R&D facilities and high investment by major players for development of advanced treatment is expected to boost the growth of target market. In addition, increasing acquisition activities by major players in order to enhance the business is expected to support the regional salmonella treatment market growth.
The market in Asia Pacific is expected to witness faster growth on the target market due to rising awareness among consumer relate to bacterial diseases. In addition, increasing government spending on development of hospital infrastructure in order to deliver enhance care and increasing R&D activities by private & public players is expected to segment the salmonella treatment market growth. In addition, favorable business policies and emergence of mid-size enterprises with innovative solutions are factors expected to boost the regional market growth.
Competitive Landscape
The global salmonella treatment market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Salmonella Treatment Market Segment Analysis, 2019
The end use segment of the global salmonella treatment market is bifurcated into hospital, clinics and other. Among end use the hospital segment is expected to account for major revenue share in the global market due to high spending on development of hospital infrastructure. The players profiled in the report are While Life Technologies, DuPont Qualicon, Hardy Diagnostics, Eiken Chemical Company Limited, Romer Labs, and Neogen Corporation.
Market Segmentation
Market By End Use
Hospital
Clinics
Others
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Frequently Asked Questions
Gradual increase in number of patients suffering from food infection and increasing awareness among consumers related to salmonella infection are major factors expected to drive the growth of global salmonella treatment market.
In end use the hospital segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are While Life Technologies, DuPont Qualicon, Hardy Diagnostics, and Eiken Chemical Company Limited.
The North America is expected to account for major revenue share in the global market.
Factors such as lack of developed food control resources and infrastructure in developing countries is expected to hamper the growth of global salmonella treatment market.
